Biotechnology Business: Indevus Announces Receipt of $49.9 Million ...

Indevus Pharmaceuticals, Inc. (NASDAQ:IDEV) announced that it has received a
$49.9 million milestone payment from Esprit Pharma, the Company's partner in
the US for SANCTURA(R)...

http://www.newsrx.com/articles/684235.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing